A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner’s solution in melasma patients

References

• Taylor A, Pawaskar M, Taylor SL, et al. Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. J Cosmet Dermatol. 2008;7:164–8
   PubMedGoogle Scholar
• Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453–7
   PubMed Web of Science ®Google Scholar
• Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB. Melasma: a clinical, light microscopic, ultrastructural and immunofluorescence study. J Am Acad Dermatol. 1981;4:698–710
   PubMed Web of Science ®Google Scholar
• Mizozochi M, Murakami F, Ito M. Clinical, pathological, and etiologic aspects of acquired dermal melanocytosis. Pigment Cell Res. 1997;10:176–83
   PubMedGoogle Scholar
• Amer M, Metwali M. Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol. 1998;37:449–50
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Finkel LJ, Voorhees JJ. Topical tretinoin improves melisma: a vehicle-controlled, clinical trial. Br J Dermatol. 1993;129;415–21
   PubMed Web of Science ®Google Scholar
• Lowe NJ, Rizk D, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20:945–59
   PubMed Web of Science ®Google Scholar
• Rashimi S. Shuchi B. Vijay KG. Chemical peels for mlasma in dark-skinned patients. J Cutan Aesthet Surg. 2012;5:247–53
   PubMedGoogle Scholar
• Cotellessa C, Peris K, Onorati MT. The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Dermatol Surg. 1999;25:450–4
   PubMed Web of Science ®Google Scholar
• Wang CC, Hui CY, Sue YM. Intense pulsed light for the treatment of refractory melisma in Asian patients. Dermatol Surg. 2004;30:1196–200
   PubMed Web of Science ®Google Scholar
• Tse Y, Levine VJ, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched Nd:YAG laser: a comparative study. J Dermatol Surg Oncol. 1994;20:795–800
   PubMedGoogle Scholar
• Katz TM, Glaich AS, Goldberg LH. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up. Dermatol Surg. 2010;36:1273–80
   PubMed Web of Science ®Google Scholar
• Choi M, Choi JW, Park KC. Low-dose 1064nm Q-switched Nd:YAG laser for the treatment of melasma. J Dermatolog Treat. 2010;21:224–8
   PubMed Web of Science ®Google Scholar
• Mun JY, Jeong SY, Kim IH. A low-fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Micros. 2011;60:11–18
   PubMedGoogle Scholar
• Cho SB, Kim JH, Kim MJ. Melasma treatment in Korean women using a 1,064nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol. 2009;34:e849–50
   PubMed Web of Science ®Google Scholar
• Bansal C, Naik H, Kar HK, Chauhan A. A Comparison of Low-fluence 1,064nm Q-switched Nd:YAG laser with topical 20% azelaic acid cream and their combination in melasma in Indian patients. J Cutan Aesthet Surg. 2012;5:266–72
   PubMedGoogle Scholar
• Kar HK, Gupta L, Chauhan A. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Indian J Dermatol Venereol Leprol. 2012;78:165–71
   PubMed Web of Science ®Google Scholar
• Park KY, Kim DH, Kim HK, Hong CK. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium–aluminium–garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Clini Exp Dermatol. 2011;36:864–70
   PubMed Web of Science ®Google Scholar
• Jeong SY, Shin JB, Yeo UC, et al. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg. 2010;36:909–18
   PubMed Web of Science ®Google Scholar
• Pandya AG, Hynan LS, Bhore R. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring metho. J Am Acad Dermatol. 2011;64:78–83
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55:1048–65
   PubMed Web of Science ®Google Scholar
• Rendon MI, Berson DS, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthetic Dermatol. 2010;3:32–43
   PubMedGoogle Scholar
• Lim JT, Tham SN. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg. 1997;23:177–9
   PubMed Web of Science ®Google Scholar
• Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner’s solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood’s light examination. J Am Acad Dermatol. 1997;36:589–93
   PubMed Web of Science ®Google Scholar
• Monheit GD. The Jessner’s + TCA peel: a medium-depth chemical peel. J Dermatol Surg Oncol. 1989;15:945–50
   PubMedGoogle Scholar
• Safoury OS, Zaki NM, Farag EA. A study comparing chemical peeling using modified Jessner’s solution and 15% trichloroacetic acid versus 15% trichloroacetic acid in the treatment of melasma. Indian J Dermatol. 2009;54:41–5
   PubMedGoogle Scholar
• Lizuka H. Epidermal turnover time. J Dermatol Sci. 1994;8:215–17
   PubMedGoogle Scholar